StockSelector.com
  Research, Select, & Monitor Saturday, December 15, 2018 11:40:37 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Ironwood Pharmaceuticals, Inc.$11.75$.484.26%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Ironwood Pharmaceuticals, Inc. has an overall rank of 6960 out of 7471 stocks based on 5 positive rankings and 12 negative rankings.

Positive Rankings
SSValue
The StockSelector Value for Ironwood Pharmaceuticals is $405.88. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Ironwood Pharmaceuticals is ranked 30.
PEGValue
Ironwood Pharmaceuticals has a PEG Value of $193.33. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 1,545.39% in the next year. Among companies with a PEG Value above the current stock price, Ironwood Pharmaceuticals is ranked 63.
Positive Stoch Cross
Ironwood Pharmaceuticals rank is 139
Estimated Revenue Growth
Ironwood Pharmaceuticals rank is 564
Historic Revenue Growth
Ironwood Pharmaceuticals rank is 970
Negative Rankings
Price-to-Book
Ironwood Pharmaceuticals rank is 18
Debt-to-Equity
Ironwood Pharmaceuticals rank is 30
Negative ROE
Ironwood Pharmaceuticals rank is 31
High vPut/Call
Ironwood Pharmaceuticals has a high Put/Call ratio of 4.15 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Ironwood Pharmaceuticals is ranked 252.
Negative Net Margin
Ironwood Pharmaceuticals rank is 599
90 Day Loss
Ironwood Pharmaceuticals rank is 760
Price-to-Sales
Ironwood Pharmaceuticals rank is 800
10 Day Loss
Ironwood Pharmaceuticals rank is 884
Negative ROA
Ironwood Pharmaceuticals rank is 976
Down EPS Surprise
Ironwood Pharmaceuticals missed the consensus earnings estimate when it last reported quarterly earnings.
Negative Cash Growth
Ironwood Pharmaceuticals rank is 1314
High Put/Call
Ironwood Pharmaceuticals has a high Put/Call ratio of 0.65 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Ironwood Pharmaceuticals is ranked 1562.







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.